Novartis Ag (NVS) FCF Margin (2009 - 2026)

Novartis Ag has disclosed FCF Margin across 18 years of filings, most recently posting 43.05% for Q2 2026.

• In Q2 2026, FCF Margin fell 672.0% year-over-year to 43.05%; the TTM figure through Jun 2026 stood at 40.85% (up 824.0% YoY), while the FY2025 annual figure was 37.94%, up 21.0% from the prior year.
• FCF Margin came in at 43.05% for Q2 2026 at Novartis Ag, up from 30.67% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 51.52% in Q3 2024 to a low of 15.21% in Q1 2022.
• Average FCF Margin over 5 years is 35.92%, with a median of 34.37% recorded in 2023.
• Year-over-year, FCF Margin sank 1480 bps in 2024 and soared 1930 bps in 2025.
• Over 5 years, FCF Margin stood at 30.28% in 2022, then rose by 17 bps to 35.51% in 2023, then plunged by 42 bps to 20.71% in 2024, then jumped by 93 bps to 40.01% in 2025, then gained by 8 bps to 43.05% in 2026.
• Per Business Quant data, the three most recent FCF Margin figures were 43.05% in Q2 2026, 30.67% in Q1 2026, and 40.01% in Q4 2025.